BioSpace News Archive

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the Company will participate in the Piper Sandler 32nd Annual Virtual Healthcare

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced at CompaMed the OVMed® Cable line of medical endoscope, catheter and dental cables, to create a platform in combination with the company’s portfolio of CameraCubeChip™ wafer-level camera modules and OVMed image signal processor (ISP) boards

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine candidate, beginning in March 2021 if it is a

Horizon Therapeutics plc (Nasdaq: HZNP) has been named to the National Association for Business Resources’ 2020 list of Best and Brightest Companies to Work For in the Nation

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced two poster presentations featuring clinical data from ongoing studies evaluating eganelisib in triple negative breast cancer (TNBC) at the upcoming San Antonio Breast Cancer Symposium (SABCS) being held virtually, December 8-11, 2020. Presentation Details: Title: MARIO-3 phase II study initial data evaluating a novel triplet combination of e

Longer follow-up research data for ENHERTU ® based on DESTINY-Breast01, including updated duration of response, progression-free survival, an 18-month landmark analysis of overall survival and longer-term safety profile to be highlighted New data from expansion cohorts of phase 1/2 study of patritumab deruxtecan in patients with HR positive, HER2 negative metastatic breast cancer with varying levels of HER3 expression or patients with HER3 high trip

PAO Group, Inc. (USOTC: PAOG) today announced publishing its Q3 2020 report with OTC Markets.

Celularity, Inc., a clinical-stage cell therapeutics company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced today the addition of two senior executives to its distinguished leadership team.

Xcelerate Solutions (Xcelerate) is excited to announce a partnership with Certify to deliver thermal scanning capabilities to our clients though the SnapXT Thermal Scanning Terminal.

International Isotopes Inc. (OTCQB: INIS) (the “Company” or “INIS”) announces its financial results for the three and nine months ended September 30, 2020.